Why the study?
Gene promoter methylation changes are considered a suitable target for therapeutic strategies, motivating investigation of CDX1 and CDX2 promoter methylation and expression in Chinese patients with gastric cancer.
Observational (n=133)
Changes in CDX1 and CDX2 gene expression, rather than promoter methylation, are associated with advanced disease stages and invasion in gastric cancer.
No takes yet. Share an insight, caveat, or question.
Jiaojiao Ma (2024) conducted an observational in Gastric cancer (n=133). CDX1 and CDX2 gene expression and promoter methylation vs. Normal tissues adjacent to the tumor and normal controls was evaluated on Promoter methylation and expression of CDX1 and CDX2 genes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: